What is the Morepen Laboratories Ltd share price today?

The share price of NSE:MOREPENLAB-EQ on 01 Oct 2026 (as of 15:04:18 IST) is ₹133.6.

What is the NSE:MOREPENLAB-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:MOREPENLAB-EQ 52 week high low range shows a high of ₹135.29 and a low of ₹33.05.

What is the Morepen Laboratories Ltd market cap?

As on 01 Oct 2026, Morepen Laboratories Ltd market cap is ₹69042200000.

What is the shareholding pattern of Morepen Laboratories Ltd Stock?

The shareholding pattern of Morepen Laboratories Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 35.65% Foreign Institutional Investors (FII): 1.46% Domestic Institutional Investors (DII): 1.28% Mutual Funds: 0% Retail & Others: 61.61% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Morepen Laboratories Ltd?

The Price-to-Earnings (PE) ratio of Morepen Laboratories Ltd is 49.1302, and the Price-to-Book (PB) ratio is 1.4858, as on 01 Oct 2026.

Morepen Laboratories Share Price

146.97+3.01 (+2.09%)

+201.60% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

+2.09%

1 Week

+9.91%

1 Month

+23.63%

3 Month

+141.09%

6 Month

+265.96%

YTD

+257.85%

1 Year

+201.60%

5 Year

+157.62%

10 Year

+516.23%

Max

+324.77%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

145.14

130.46

97.04

51.38

38.30

33.04

High

150.70

About

Morepen Laboratories is engaged in the manufacturing and sale of APis/ Bulk Drugs Home Diagnostics Formulations and OTC products. The plant at Masulkhana is for manufacture of Loratadine an anti-allergy Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

LAURUSLABSNSE

CIPLANSE

MANKINDNSE

DRREDDYNSE

AUROPHARMANSE

LUPINNSE

MOREPENLABNSE

LTP

1W Low

1W High

Market cap (₹)

1781-20 (-1.11%)

1768

1804.20

4,32,120Cr

9588+339 (3.67%)

9113.50

9660

2,53,390Cr

4716.2-51.1 (-1.07%)

4679

4795

1,81,740Cr

1153+7.3 (0.64%)

1128.10

1167.40

1,15,710Cr

2052.8+68.8 (3.47%)

1955.10

2065.20

1,10,980Cr

1327.2-16.8 (-1.25%)

1321

1351

1,08,497Cr

2500-35 (-1.38%)

2464.50

2539.30

1,02,650Cr

1203.8-2.4 (-0.20%)

1189

1222.80

1,00,925Cr

1682+5.2 (0.31%)

1663.10

1698.90

97,239Cr

2012.9-18.3 (-0.90%)

1996.30

2031.40

93,059Cr

146.97+13.25 (9.91%)

130.46

150.70

7,877Cr

Morepen Laboratories Share Price

146.97+3.01 (+2.09%)

+201.60% past 1 Year

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Morepen Laboratories Share Price

146.97+3.01 (+2.09%)

+201.60% past 1 Year

Financial overview

Compounded Sales Growth

10 years14%

5 years9%

3 years8%

Last year0%

Compounded Profit Growth

10 years22%

5 years0%

3 years35%

Last year-19%

Stock Price CAGR

10 years20%

5 years20%

3 years59%

1 year195%

Return on Equity

10 years14%

5 years12%

3 years11%

Last year8%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
14%	9%	8%	0%
22%	0%	35%	-19%
20%	20%	59%	195%
14%	12%	11%	8%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

LAURUSLABS

CIPLA

MANKIND

DRREDDY

AUROPHARMA

LUPIN

MOREPENLAB

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,781	₹432120 Cr	35.73	12.07	62.82	₹11479 Cr
9,588	₹253390 Cr	86.63	34.04	128.41	₹2568 Cr
4,716.2	₹181740 Cr	83.33	16.72	97.06	₹2163 Cr
1,153	₹115710 Cr	25.64	9.42	62.53	₹5040 Cr
2,052.8	₹110980 Cr	101.5	6.8	29.25	₹889 Cr
1,327.2	₹108497 Cr	32.19	9.77	57.87	₹3879 Cr
2,500	₹102650 Cr	50.25	13.75	71.08	₹1913 Cr
1,203.8	₹100925 Cr	31.32	5.32	63.99	₹4196 Cr
1,682	₹97239 Cr	26.19	17.95	96.84	₹3505 Cr
2,012.9	₹93059 Cr	16.83	30.95	154.35	₹5333 Cr
146.97	₹7877 Cr	56.05	1.03	3.22	₹95 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018	Mar 2018	Dec 2017	Sep 2017	Jun 2017	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2006
₹570 Cr	₹485 Cr	₹484 Cr	₹412 Cr	₹425 Cr	₹466 Cr	₹453 Cr	₹438 Cr	₹455 Cr	₹423 Cr	₹445 Cr	₹422 Cr	₹401 Cr	₹364 Cr	₹348 Cr	₹403 Cr	₹302 Cr	₹368 Cr	₹397 Cr	₹395 Cr	₹387 Cr	₹287 Cr	₹307 Cr	₹336 Cr	₹258 Cr	₹207 Cr	₹230 Cr	₹213 Cr	₹203 Cr	₹219 Cr	₹212 Cr	₹174 Cr	₹164 Cr	₹171 Cr	₹155 Cr	₹150 Cr	₹131 Cr	₹60 Cr	₹51 Cr	₹44 Cr	₹39 Cr	₹37 Cr
₹5 Cr	₹8 Cr	₹4 Cr	₹5 Cr	₹4 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹1 Cr	₹87 L	₹91 L	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹4 Cr	₹3 Cr	₹4 Cr	₹1 Cr	₹2 Cr	₹5 Cr	₹3 Cr	₹28 L	₹1 Cr	₹2 Cr	₹13 L	₹8 L	₹30 L	₹1 Cr	₹86 L	₹1 Cr	₹0	₹0	₹0	₹38 L	₹4 L
₹575 Cr	₹493 Cr	₹488 Cr	₹416 Cr	₹430 Cr	₹470 Cr	₹458 Cr	₹443 Cr	₹459 Cr	₹427 Cr	₹449 Cr	₹425 Cr	₹403 Cr	₹367 Cr	₹350 Cr	₹404 Cr	₹303 Cr	₹371 Cr	₹399 Cr	₹398 Cr	₹388 Cr	₹291 Cr	₹310 Cr	₹340 Cr	₹259 Cr	₹208 Cr	₹235 Cr	₹216 Cr	₹203 Cr	₹220 Cr	₹215 Cr	₹174 Cr	₹164 Cr	₹172 Cr	₹156 Cr	₹151 Cr	₹132 Cr	₹60 Cr	₹51 Cr	₹44 Cr	₹40 Cr	₹37 Cr
₹496 Cr	₹466 Cr	₹448 Cr	₹392 Cr	₹410 Cr	₹440 Cr	₹422 Cr	₹396 Cr	₹409 Cr	₹384 Cr	₹402 Cr	₹396 Cr	₹383 Cr	₹355 Cr	₹335 Cr	₹381 Cr	₹295 Cr	₹356 Cr	₹371 Cr	₹360 Cr	₹350 Cr	₹263 Cr	₹285 Cr	₹312 Cr	₹239 Cr	₹196 Cr	₹223 Cr	₹207 Cr	₹195 Cr	₹208 Cr	₹205 Cr	₹167 Cr	₹161 Cr	₹164 Cr	₹145 Cr	₹138 Cr	₹129 Cr	₹70 Cr	₹62 Cr	₹52 Cr	₹52 Cr	₹50 Cr
₹88 Cr	₹33 Cr	₹50 Cr	₹35 Cr	₹29 Cr	₹47 Cr	₹41 Cr	₹49 Cr	₹55 Cr	₹53 Cr	₹55 Cr	₹37 Cr	₹29 Cr	₹19 Cr	₹22 Cr	₹30 Cr	₹15 Cr	₹22 Cr	₹35 Cr	₹45 Cr	₹45 Cr	₹35 Cr	₹33 Cr	₹35 Cr	₹28 Cr	₹21 Cr	₹20 Cr	₹18 Cr	₹20 Cr	₹23 Cr	₹19 Cr	₹17 Cr	₹12 Cr	₹18 Cr	₹19 Cr	₹20 Cr	₹11 Cr	₹2 Cr	₹1 Cr	₹6 Cr	₹56 L	₹3 Cr
₹5 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹80 L	₹2 Cr	₹46 L	₹28 L	₹56 L	₹55 L	₹47 L	₹40 L	₹80 L	₹75 L	-₹9 Cr	₹21 L	-₹5 L	₹1 Cr	₹29 L	₹29 L	₹62 L	₹54 L	₹39 L	₹43 L	₹93 L	₹43 L	₹32 L	₹44 L	₹81 L	₹91 L	₹1 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹64 L	₹4 L	₹15 L
₹75 Cr	₹23 Cr	₹35 Cr	₹46 Cr	₹16 Cr	₹26 Cr	₹35 Cr	₹46 Cr	₹48 Cr	₹42 Cr	₹44 Cr	₹29 Cr	₹21 Cr	₹11 Cr	₹14 Cr	₹22 Cr	₹8 Cr	₹14 Cr	₹27 Cr	₹47 Cr	₹39 Cr	₹28 Cr	₹24 Cr	₹28 Cr	₹20 Cr	₹11 Cr	₹11 Cr	₹9 Cr	₹8 Cr	₹11 Cr	₹9 Cr	₹7 Cr	₹3 Cr	₹7 Cr	₹10 Cr	₹11 Cr	₹1 Cr	-₹12 Cr	-₹13 Cr	-₹8 Cr	-₹13 Cr	-₹13 Cr
₹56 Cr	₹16 Cr	₹27 Cr	₹41 Cr	₹11 Cr	₹20 Cr	₹27 Cr	₹35 Cr	₹36 Cr	₹29 Cr	₹32 Cr	₹21 Cr	₹15 Cr	₹8 Cr	₹9 Cr	₹16 Cr	₹6 Cr	₹12 Cr	₹22 Cr	₹37 Cr	₹30 Cr	₹27 Cr	₹24 Cr	₹27 Cr	₹19 Cr	₹11 Cr	₹11 Cr	₹4 Cr	₹8 Cr	₹10 Cr	₹9 Cr	₹7 Cr	₹2 Cr	₹7 Cr	₹10 Cr	₹11 Cr	₹1 Cr	-₹11 Cr	-₹13 Cr	-₹77 L	-₹4 Cr	-₹9 Cr

Balance Sheet

Consolidated

Standalone

₹

%

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Miscellaneous Expenses not written off

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹110 Cr	₹110 Cr	₹102 Cr	₹102 Cr	₹96 Cr	₹90 Cr	₹90 Cr	₹90 Cr	₹90 Cr	₹90 Cr	₹210 Cr	₹210 Cr	₹210 Cr	₹210 Cr	₹210 Cr	₹210 Cr	₹210 Cr	₹191 Cr	₹191 Cr	₹65 Cr
₹0	₹0	₹0	₹0	₹26 Cr	₹44 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹3 Cr	₹3 Cr	₹137 Cr
₹1137 Cr	₹1047 Cr	₹745 Cr	₹651 Cr	₹457 Cr	₹291 Cr	₹194 Cr	₹163 Cr	₹136 Cr	₹106 Cr	₹91 Cr	₹78 Cr	₹88 Cr	₹90 Cr	₹111 Cr	₹134 Cr	₹181 Cr	₹99 Cr	₹147 Cr	₹39 Cr
₹1137 Cr	₹1047 Cr	₹745 Cr	₹651 Cr	₹457 Cr	₹291 Cr	₹194 Cr	₹163 Cr	₹136 Cr	₹106 Cr	₹91 Cr	₹78 Cr	₹88 Cr	₹90 Cr	₹111 Cr	₹134 Cr	₹181 Cr	₹99 Cr	₹147 Cr	₹39 Cr
₹1246 Cr	₹1156 Cr	₹847 Cr	₹753 Cr	₹579 Cr	₹425 Cr	₹284 Cr	₹253 Cr	₹226 Cr	₹196 Cr	₹300 Cr	₹287 Cr	₹297 Cr	₹300 Cr	₹320 Cr	₹344 Cr	₹391 Cr	₹293 Cr	₹341 Cr	₹241 Cr
₹65 L	₹31 Cr	₹0	-₹46 L	-₹46 L	-₹46 L	-₹46 L	-₹46 L	-₹45 L	-₹63 L	-₹63 L	-₹40 L	-₹40 L	-₹43 L	-₹42 L	-₹44 L	-₹44 L	-₹36 L	-₹29 L	-₹29 L
₹4 Cr	₹6 Cr	₹3 Cr	₹93 L	₹1 Cr	₹83 L	₹92 L	₹2 Cr	₹3 Cr	₹1 Cr	₹43 Cr	₹62 Cr	₹75 Cr	₹95 Cr	₹99 Cr	₹114 Cr	₹128 Cr	₹137 Cr	₹144 Cr	₹304 Cr
₹129 Cr	₹20 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹15 Cr	₹14 Cr	₹11 Cr	₹144 Cr	₹148 Cr	₹194 Cr
₹16 Cr	₹7 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹7 Cr	₹18 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹0	₹0	₹0	₹0
₹41 Cr	₹40 Cr	₹34 Cr	₹30 Cr	₹28 Cr	₹25 Cr	₹24 Cr	₹19 Cr	₹14 Cr	₹14 Cr	₹11 Cr	₹9 Cr	₹8 Cr	₹7 Cr	₹6 Cr	₹4 Cr	₹0	₹0	₹0	₹0
₹199 Cr	₹90 Cr	₹44 Cr	₹37 Cr	₹35 Cr	₹30 Cr	₹28 Cr	₹23 Cr	₹20 Cr	₹18 Cr	₹57 Cr	₹74 Cr	₹85 Cr	₹104 Cr	₹122 Cr	₹135 Cr	₹140 Cr	₹280 Cr	₹292 Cr	₹498 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹317 Cr	₹363 Cr	₹295 Cr	₹227 Cr	₹258 Cr	₹209 Cr	₹172 Cr	₹168 Cr	₹175 Cr	₹125 Cr	₹115 Cr	₹85 Cr	₹69 Cr	₹57 Cr	₹65 Cr	₹60 Cr	₹82 Cr	₹78 Cr	₹71 Cr	₹70 Cr
₹106 Cr	₹72 Cr	₹59 Cr	₹55 Cr	₹170 Cr	₹174 Cr	₹165 Cr	₹161 Cr	₹164 Cr	₹199 Cr	₹47 Cr	₹40 Cr	₹38 Cr	₹45 Cr	₹39 Cr	₹41 Cr	₹0	₹11 L	₹25 L	₹87 L
₹37 Cr	₹46 Cr	₹23 Cr	₹23 Cr	₹16 Cr	₹15 Cr	₹11 Cr	₹9 Cr	₹0	₹0	₹0	₹2 Cr	₹1 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹30 Cr	₹20 Cr	₹25 Cr	₹16 Cr	₹12 Cr	₹5 Cr	₹3 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹4 Cr	₹86 L	₹77 L	₹70 L	₹1 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr
₹490 Cr	₹501 Cr	₹402 Cr	₹321 Cr	₹456 Cr	₹404 Cr	₹351 Cr	₹339 Cr	₹340 Cr	₹325 Cr	₹167 Cr	₹128 Cr	₹108 Cr	₹103 Cr	₹105 Cr	₹103 Cr	₹85 Cr	₹81 Cr	₹73 Cr	₹73 Cr
₹1936 Cr	₹1778 Cr	₹1293 Cr	₹1111 Cr	₹1070 Cr	₹858 Cr	₹663 Cr	₹615 Cr	₹586 Cr	₹538 Cr	₹524 Cr	₹489 Cr	₹490 Cr	₹506 Cr	₹547 Cr	₹581 Cr	₹616 Cr	₹653 Cr	₹706 Cr	₹811 Cr
₹335 Cr	₹18 Cr	₹10 Cr	₹7 Cr	₹3 Cr	₹93 L	₹1 Cr	₹12 Cr	₹26 Cr	₹32 Cr	₹28 Cr	₹33 Cr	₹33 Cr	₹35 Cr	₹13 Cr	₹5 Cr	₹4 Cr	₹85 Cr	₹20 Cr	₹25 Cr
₹195 Cr	₹79 Cr	₹29 Cr	₹25 Cr	₹19 Cr	₹17 Cr	₹13 Cr	₹132 Cr	₹15 Cr	₹49 Cr	₹68 Cr	₹81 Cr	₹89 Cr	₹111 Cr	₹121 Cr	₹133 Cr	₹140 Cr	₹280 Cr	₹292 Cr	₹498 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹797 Cr	₹828 Cr	₹621 Cr	₹656 Cr	₹613 Cr	₹628 Cr	₹753 Cr	₹888 Cr	₹998 Cr	₹1027 Cr	₹1018 Cr	₹1009 Cr	₹1005 Cr	₹1000 Cr	₹997 Cr	₹998 Cr	₹996 Cr	₹991 Cr	₹1003 Cr	₹1002 Cr
₹284 Cr	₹340 Cr	₹313 Cr	₹389 Cr	₹361 Cr	₹404 Cr	₹536 Cr	₹652 Cr	₹733 Cr	₹755 Cr	₹722 Cr	₹687 Cr	₹637 Cr	₹591 Cr	₹546 Cr	₹502 Cr	₹455 Cr	₹408 Cr	₹365 Cr	₹317 Cr
₹513 Cr	₹489 Cr	₹307 Cr	₹267 Cr	₹252 Cr	₹225 Cr	₹216 Cr	₹236 Cr	₹264 Cr	₹272 Cr	₹297 Cr	₹322 Cr	₹368 Cr	₹409 Cr	₹452 Cr	₹496 Cr	₹540 Cr	₹583 Cr	₹638 Cr	₹686 Cr
₹22 Cr	₹28 Cr	₹24 Cr	₹17 Cr	₹14 Cr	₹2 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹101 Cr	₹7 Cr	₹1 Cr	₹0	₹0	₹1 Cr	₹1 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr
₹101 Cr	₹7 Cr	₹1 Cr	₹0	₹0	₹1 Cr	₹1 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr
₹136 Cr	₹94 Cr	₹71 Cr	₹70 Cr	₹70 Cr	₹104 Cr	₹74 Cr	₹79 Cr	₹78 Cr	₹74 Cr	₹70 Cr	₹52 Cr	₹25 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹0	₹0	₹0	₹0
₹27 L	₹23 L	₹24 L	₹28 L	₹28 L	₹27 L	₹28 L	₹28 L	₹27 L	₹85 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹773 Cr	₹619 Cr	₹404 Cr	₹354 Cr	₹336 Cr	₹331 Cr	₹291 Cr	₹316 Cr	₹342 Cr	₹346 Cr	₹367 Cr	₹374 Cr	₹393 Cr	₹415 Cr	₹457 Cr	₹501 Cr	₹544 Cr	₹587 Cr	₹642 Cr	₹690 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹23 Cr	₹78 Cr	₹0	₹0	₹0	₹0	₹0	₹2 L	₹22 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹272 Cr	₹300 Cr	₹249 Cr	₹229 Cr	₹276 Cr	₹175 Cr	₹138 Cr	₹94 Cr	₹77 Cr	₹65 Cr	₹42 Cr	₹37 Cr	₹33 Cr	₹37 Cr	₹39 Cr	₹35 Cr	₹32 Cr	₹22 Cr	₹19 Cr	₹18 Cr
₹333 Cr	₹325 Cr	₹325 Cr	₹263 Cr	₹251 Cr	₹182 Cr	₹138 Cr	₹134 Cr	₹122 Cr	₹93 Cr	₹88 Cr	₹56 Cr	₹43 Cr	₹39 Cr	₹35 Cr	₹30 Cr	₹24 Cr	₹21 Cr	₹13 Cr	₹10 Cr
₹69 Cr	₹49 Cr	₹52 Cr	₹56 Cr	₹46 Cr	₹68 Cr	₹39 Cr	₹32 Cr	₹6 Cr	₹8 Cr	₹4 Cr	₹9 Cr	₹9 Cr	₹6 Cr	₹5 Cr	₹3 Cr	₹1 Cr	₹5 Cr	₹15 Cr	₹68 Cr
₹107 Cr	₹72 Cr	₹16 Cr	₹7 Cr	₹5 Cr	₹10 Cr	₹6 Cr	₹8 Cr	₹5 Cr	₹3 Cr	₹5 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹4 Cr	₹4 Cr
₹360 Cr	₹336 Cr	₹247 Cr	₹201 Cr	₹157 Cr	₹92 Cr	₹51 Cr	₹31 Cr	₹34 Cr	₹23 Cr	₹17 Cr	₹10 Cr	₹8 Cr	₹7 Cr	₹10 Cr	₹10 Cr	₹11 Cr	₹15 Cr	₹9 Cr	₹8 Cr
₹1164 Cr	₹1159 Cr	₹889 Cr	₹756 Cr	₹734 Cr	₹527 Cr	₹372 Cr	₹299 Cr	₹243 Cr	₹192 Cr	₹157 Cr	₹115 Cr	₹96 Cr	₹91 Cr	₹90 Cr	₹80 Cr	₹70 Cr	₹65 Cr	₹60 Cr	₹109 Cr
₹673 Cr	₹659 Cr	₹487 Cr	₹435 Cr	₹278 Cr	₹123 Cr	₹21 Cr	-₹40 Cr	-₹97 Cr	-₹133 Cr	-₹9 Cr	-₹13 Cr	-₹12 Cr	-₹12 Cr	-₹15 Cr	-₹23 Cr	-₹15 Cr	-₹16 Cr	-₹13 Cr	₹37 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹1 Cr	₹1 Cr	₹5 Cr	₹12 Cr
₹1936 Cr	₹1778 Cr	₹1293 Cr	₹1111 Cr	₹1070 Cr	₹858 Cr	₹663 Cr	₹615 Cr	₹586 Cr	₹538 Cr	₹524 Cr	₹489 Cr	₹490 Cr	₹506 Cr	₹547 Cr	₹581 Cr	₹616 Cr	₹653 Cr	₹706 Cr	₹811 Cr
₹23	₹21	₹17	₹15	₹12	₹8	₹6	₹6	₹5	₹4	₹4	₹4	₹4	₹4	₹4	₹5	₹6	₹5	₹6	₹3
₹23	₹21	₹17	₹15	₹12	₹8	₹6	₹6	₹5	₹4	₹4	₹4	₹4	₹4	₹4	₹5	₹6	₹5	₹6	₹3

Cash Flow

Consolidated

Standalone

₹

%

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007
₹120 Cr	₹155 Cr	₹135 Cr	₹56 Cr	₹127 Cr	₹99 Cr	₹39 Cr	₹29 Cr	₹30 Cr	₹23 Cr	₹17 Cr	₹2 Cr	-₹6 Cr	-₹24 Cr	-₹36 Cr	-₹48 Cr	-₹40 Cr	-₹49 Cr	-₹68 Cr	-₹48 Cr
₹33 Cr	₹38 Cr	₹34 Cr	₹28 Cr	₹19 Cr	₹32 Cr	₹37 Cr	₹40 Cr	₹39 Cr	₹41 Cr	₹46 Cr	₹47 Cr	₹56 Cr	₹57 Cr	₹56 Cr	₹54 Cr	₹52 Cr	₹54 Cr	₹67 Cr	₹56 Cr
-₹95 Cr	-₹124 Cr	-₹58 Cr	-₹158 Cr	-₹181 Cr	-₹78 Cr	-₹59 Cr	-₹52 Cr	-₹5 Cr	-₹24 Cr	-₹8 Cr	₹1 Cr	-₹20 Cr	-₹3 Cr	-₹5 Cr	₹4 Cr	-₹5 Cr	-₹8 Cr	-₹3 Cr	₹347 Cr
₹58 Cr	₹69 Cr	₹111 Cr	-₹75 Cr	-₹35 Cr	₹52 Cr	₹17 Cr	₹18 Cr	₹63 Cr	₹41 Cr	₹54 Cr	₹51 Cr	₹31 Cr	₹31 Cr	₹15 Cr	₹10 Cr	₹7 Cr	-₹3 Cr	-₹4 Cr	₹355 Cr
₹33 Cr	₹32 Cr	₹73 Cr	-₹91 Cr	-₹60 Cr	₹51 Cr	₹11 Cr	₹17 Cr	₹63 Cr	₹41 Cr	₹50 Cr	₹51 Cr	₹34 Cr	₹34 Cr	₹27 Cr	₹11 Cr	₹7 Cr	-₹3 Cr	₹8 Cr	₹270 Cr
-₹123 Cr	-₹322 Cr	-₹83 Cr	-₹47 Cr	-₹32 Cr	-₹70 Cr	-₹12 Cr	-₹13 Cr	-₹27 Cr	-₹14 Cr	-₹27 Cr	-₹32 Cr	-₹80 L	-₹3 Cr	-₹3 Cr	-₹4 Cr	-₹4 Cr	-₹1 Cr	-₹72 L	₹8 Cr
₹97 Cr	₹300 Cr	₹5 Cr	₹144 Cr	₹66 Cr	₹47 Cr	₹5 Cr	-₹44 L	-₹38 Cr	-₹24 Cr	-₹27 Cr	-₹19 Cr	-₹29 Cr	-₹30 Cr	-₹22 Cr	-₹6 Cr	-₹6 Cr	-₹6 Cr	-₹61 Cr	-₹281 Cr
₹7 Cr	₹10 Cr	-₹5 Cr	₹6 Cr	-₹26 Cr	₹28 Cr	₹4 Cr	₹4 Cr	-₹1 Cr	₹3 Cr	-₹4 Cr	-₹26 L	₹4 Cr	₹1 Cr	₹2 Cr	₹1 Cr	-₹3 Cr	-₹11 Cr	-₹53 Cr	-₹3 Cr
₹27 Cr	₹17 Cr	₹22 Cr	₹16 Cr	₹41 Cr	₹14 Cr	₹10 Cr	₹6 Cr	₹7 Cr	₹4 Cr	₹9 Cr	₹9 Cr	₹6 Cr	₹5 Cr	₹3 Cr	₹1 Cr	₹5 Cr	₹15 Cr	₹68 Cr	₹71 Cr
-₹3 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹31 Cr	₹27 Cr	₹17 Cr	₹22 Cr	₹16 Cr	₹41 Cr	₹14 Cr	₹10 Cr	₹6 Cr	₹7 Cr	₹4 Cr	₹9 Cr	₹9 Cr	₹6 Cr	₹5 Cr	₹3 Cr	₹1 Cr	₹5 Cr	₹15 Cr	₹68 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Morepen Laboratories Share Price

146.97+3.01 (+2.09%)

+201.60% past 1 Year

Technical meters

Oscillators

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 6

Bearish signals: 3 out of 9 oscillators

RSI

77.26Buy

STOCH %K

90.20Sell

MACD Level(12,26)

10.42Buy

Ultimate Oscillator

61.50Buy

Aroon Oscillator

100.00Buy

BOP

0.30Buy

CCI

246.91Sell

Williams %R

-9.80Sell

Momentum

32.24Buy

Moving averages

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 9

Bearish signals: 0 out of 9 moving averages

EMA 9

132.71Buy

SMA 9

129.16Buy

EMA 21

122.87Buy

SMA 21

122.49Buy

EMA 50

104.95Buy

SMA 50

101.18Buy

EMA 200

70.19Buy

SMA 200

58.15Buy

WMA 20

126.96Buy

Pivot

Classic

Resistance 5

180.17

Resistance 4

170.53

Resistance 3

160.89

Resistance 2

151.25

Resistance 1

147.60

Pivot

141.61

Support 1

137.96

Support 2

131.97

Support 3

122.33

Support 4

112.69

Support 5

103.05

High & lows

1 Day

1 Week

1 Month

3 Months

6 Months

Year to Date

1 Year

3 Years

5 Years

10 Years

All Time

Low

145.14

130.46

97.04

51.38

38.30

33.05

33.04

31.30

23.60

7.20

2.05

High

150.70

218.00

Returns

+3.01

+13.25

+28.09

+86.01

+106.81

+105.90

+98.24

+110.87

+89.92

+123.12

+112.37

Beta

—

Std. deviation %

—

Sign in to view

Open a free Demat account in minutes to start investing and screening .

Morepen Laboratories Share Price

146.97+3.01 (+2.09%)

+201.60% past 1 Year

Shareholding summary

Promoters

35.65%

FII

1.46%

DII

1.28%

MF

0%

Others

61.61%

Promoters

FII

DII

MF

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
35.65%	35.65%	35.65%	35.65%	35.65%	35.65%
1.46%	1.58%	1.62%	1.62%	1.72%	1.94%
1.28%	1.25%	1.25%	1.49%	1.50%	1.67%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
61.61%	61.52%	61.48%	61.24%	61.13%	60.74%

Bulk & block deals

Name

Hrti Private Limited

Qe Securities Llp

Hrti Private Limited

Qe Securities Llp

Hrti Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
16 Sep 2026	Purchase	26.83 Cr	₹106.12	25.28 L	Bulk	0.461433	NSE
16 Sep 2026	Sell	30.16 Cr	₹107.18	28.14 L	Bulk	0.513457	NSE
31 Aug 2026	Purchase	33.51 Cr	₹105.50	31.76 L	Bulk	0.579666	NSE
31 Aug 2026	Sell	33.74 Cr	₹105.94	31.85 L	Bulk	0.581209	NSE
20 Aug 2026	Purchase	28.08 Cr	₹93.44	30.06 L	Bulk	0.548524	NSE
20 Aug 2026	Purchase	27.56 Cr	₹93.91	29.35 L	Bulk	0.535563	NSE
20 Aug 2026	Sell	29.10 Cr	₹93.72	31.05 L	Bulk	0.566619	NSE
20 Aug 2026	Sell	27.69 Cr	₹93.39	29.65 L	Bulk	0.541035	NSE
17 Aug 2026	Purchase	32.06 Cr	₹87.31	36.72 L	Bulk	0.670182	NSE
17 Aug 2026	Sell	36.03 Cr	₹87.28	41.28 L	Bulk	0.753288	NSE

Insider trading & SAST

Client name

Scope Credits And Financial Services Private Limited

Liquid Holdings Private Limited

React Investments And Financial Services Private Limited

Mid-Med Financial Services And Investments Private Limited

Brook Investments And Financial Services Private Limited

Square Investments And Financial Services Private Limited

Solitary Investments And Financial Services Private Limited

Solace Investments And Financial Services Private Limited

Seed Securities And Services Private Limited

Scope Credits And Financial Services Private Limited

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
24 Dec 2024	Promoter	Others	—	—	0	—	6.10 L	29 Oct 2016	Release	0	SAST	Reg31	—
22 Sep 2022	Promoter Group	Acquisition	1.001732	0.98	12.50 Cr	₹25	50 L	21 Sep 2022	Conversion of security	50,03,000	Insider Trading	—	Equity Shares
22 Sep 2022	Promoter Group	Acquisition	0.701212	2.92	8.75 Cr	₹25	35 L	21 Sep 2022	Conversion of security	1,49,42,134	Insider Trading	—	Equity Shares
22 Sep 2022	Promoter Group	Acquisition	0.701212	2.93	8.75 Cr	₹25	35 L	21 Sep 2022	Conversion of security	1,49,73,813	Insider Trading	—	Equity Shares
05 Apr 2022	Promoter Group	Acquisition	0.778136	3.17	8.75 Cr	₹25	35 L	30 Mar 2022	Conversion of security	1,51,59,252	Insider Trading	—	Equity Shares
05 Apr 2022	Promoter Group	Acquisition	0.778136	2.95	8.75 Cr	₹25	35 L	30 Mar 2022	Conversion of security	1,41,02,075	Insider Trading	—	Equity Shares
05 Apr 2022	Promoter Group	Acquisition	0.778136	3.16	8.75 Cr	₹25	35 L	30 Mar 2022	Conversion of security	1,51,14,045	Insider Trading	—	Equity Shares
05 Apr 2022	Promoter Group	Acquisition	0.778136	3.16	8.75 Cr	₹25	35 L	30 Mar 2022	Conversion of security	1,50,82,790	Insider Trading	—	Equity Shares
05 Apr 2022	Promoter Group	Acquisition	0.778136	3	8.75 Cr	₹25	35 L	30 Mar 2022	Conversion of security	1,43,28,780	Insider Trading	—	Equity Shares
05 Apr 2022	Promoter Group	Acquisition	0.778136	3.26	8.75 Cr	₹25	35 L	30 Mar 2022	Conversion of security	1,55,75,405	Insider Trading	—	Equity Shares

Morepen Laboratories Share Price

146.97+3.01 (+2.09%)

+201.60% past 1 Year

Morepen Laboratories is engaged in the manufacturing and sale of APis/ Bulk Drugs Home Diagnostics Formulations and OTC products. The plant at Masulkhana is for manufacture of Loratadine an anti-allergy

Corporate Actions

Date

Type

Details

2026-09-18

Dividend

0.2

2025-08-29

Dividend

0.2

Company details

Registered office

Morepen Village, Malkumajra Nalagarh Road Near Baddi Solan Dist Himachal Pradesh PIN: 173205 Tel No: 01795-246401 / 02 / 03 / 244590 Fax No: 01795-244591 Email: [email protected] Internet: www.morepen.com

Registrars

T-34, 2nd Floor, Okhla Industrial Area, Phase - II, New Delhi - 110020 T-34 , 2nd Floor Okhla Industrial Area Phase - II PIN: Tel No: 011-26387281/82/83 Fax No: 011-26387384 Email: NULL Internet: www.masserv.com

Management

Vipul Kumar Srivastava, Company Secretary & Compliance Officer

Sushil Suri, Chairman & Managing Director

Sanjay Suri, Managing Director

Praveen Kumar Dutt, Non Executive Independent Director

Ranjit Khattar , Non Executive Independent Director

Sharad Jain, Non Executive Independent Director

Savita, Non Executive Independent Director

Details

BSE 500288

NSE MOREPENLAB

ISIN INE083A01026